A Boston-based biopharmaceutical company is revolutionizing the weight-loss drug industry. Syntis Bio has created a daily ...

Beyond 2 years, CABG with flow assessment was associated with a higher risk for new coronary angiography and new ...

Weight loss can reverse the cardiovascular changes that take place in the heart, but will a new diet and exercise work, or is ...

Q1 2025 Earnings Call Transcript May 14, 2025 Cytosorbents Corporation beats earnings expectations. Reported EPS is $-0.06, ...

Although it calls for careful thought, it might become required to address ongoing problems, raise the standard of living, or ...

The millions of people living with obesity need novel treatment options that are safe, effective and avoid the high costs and ...

A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrates positive ...

A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrated positive preliminary data for the safe and effective redirection of nutrient absorption into ...

A no-touch vein harvesting technique reduces vein graft occlusion and improves patient outcomes at 3-year follow-up among patients undergoing CABG surgery.

Results presented here showed ACL reconstruction with lateral extra-articular tenodesis led to a decrease in overall graft ...

Utilizing lasers, balloons and a heart-lung machine, a local physician is credited with bringing multiple new cardiology ...

The former All-Pro defensive back Trevon Diggs looks like he is doing everything he can to return to Dallas Cowboys ...